1 / 31

Jaclyn Bibby , Jens Thomas, Olga Mayans and Daniel Rigden Institute of Integrative Biology

AMPLE – Using ab initio protein structure modelling techniques to create and enhance search models for use in Molecular Replacement. Ronan Keegan and Martyn Winn Collaborative Computational Project 4 (CCP4). Jaclyn Bibby , Jens Thomas, Olga Mayans and Daniel Rigden

kory
Download Presentation

Jaclyn Bibby , Jens Thomas, Olga Mayans and Daniel Rigden Institute of Integrative Biology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AMPLE – Using ab initio protein structure modelling techniques to create and enhance search models for use in Molecular Replacement Ronan Keegan and Martyn Winn Collaborative Computational Project 4 (CCP4) Jaclyn Bibby, Jens Thomas, Olga Mayans and Daniel Rigden Institute of Integrative Biology

  2. AMPLE ab initio modelling of proteins for molecular replacement • Joint development by CCP4 and the University of Liverpool • AMPLE is a comprehensive project to assess the suitability of using cheaply obtained ab initio models in molecular replacement • An additional goal of the project is to make AMPLE into an automated software tool that can be made generally available to potential users through CCP4

  3. Ab initio structure prediction • Ab initio (or de novo) structure prediction is the prediction of a target structure fold based purely on its sequence information • Methods have greatly improved in recent years with the aid of the CASP experiments (Critical Assessment of Protein structure prediction) • Some examples are: • Rosetta • I-TASSER • QUARK

  4. Ab initio structure prediction • 1000’s of “Decoys” assembled of fragments from PDB structures • Decoys are clustered and centroid representatives of largest cluster are considered candidate fold predictions • Side chains added to selected decoys • Refinement under a more realistic physics-based force field • Initial fragment assembly stage requires relatively modest computing power • Refinement stage can require supercomputing resources

  5. Ab initio structure prediction • 1000’s of “Decoys” assembled of fragments from PDB structures • Decoys are clustered and centroid representatives of largest cluster are considered candidate fold predictions • Side chains added to selected decoys • Refinement under a more realistic physics-based force field • Initial fragment assembly stage requires relatively modest computing power • Refinement stage can require supercomputing resources

  6. Ab initio modelling and Molecular Replacement • Combining this method with molecular replacement can be a powerful technique for solving the phase problem in cases where there are no obvious homologous structures available • Two approaches have been taken • All-atom modelling to produce single search models of maximum completeness and accuracy (Qian et. al, 2007) • Solved 1/3 of test set of 30 targets (Das et. al, 2009) • Computationally expensive • Taking cheaply obtained decoys from the initial fragment assembly step and preparing them has been shown to produce successful MR search models (Rigden et al. 2008, Caliandor 2009)

  7. Synergies

  8. The AMPLE Pipeline • Uses Rosetta to perform ab initio modelling and the generation of decoy models • Can also accept models generated externally • Currently designed for < 120 residues and resolution better than 2.2 Å (but may work outside these restrictions e.g. transmembrane, coiled-coil proteins)

  9. Decoy Generation • Decoys generated first with Rosetta • Quark has also been used during development • Typical number of decoys required is 1000 but this can be varied • In easier cases as few as 50 decoys can be sufficient

  10. Decoy Clustering • Clustering using SPICKER to identify the most likely fold for the target • A large top cluster is usually indicative of a correct prediction • A subset of decoys (max. 200) closest to the centroid of each of the largest 3 clusters are selected for further processing

  11. Decoy Clustering • Each cluster is then structurally aligned using the maximum likelihood algorithm implemented in Theseus (Theobold & Wuttke, 2006) • This helps to identify structurally conserved regions • Gives a variance score which can later be used to guide truncation

  12. Ensemble Truncation • We’ve found that success or failure in the molecular replacement step is highly sensitive to the accuracy of the search model • Sampling many degrees of truncation with different levels of side chain inclusion is essential • High variance regions are cut away in steps to give a set of ensemble models

  13. Further processing • These truncated clusters are further processed and side chains are added to give a large set of search models for molecular replacement

  14. Molecular replacement • Molecular replacement is performed using MrBUMP from the CCP4 suite which automates the procedure • Search models are processed by both Phaser and Molrep • Post molecular replacement, positioned search models are refined using Refmac5 to get an initial indication of success or failure • C-alpha tracing with SHELXE, model building with Buccaneer, ARP/wARP

  15. Testing • Test set of 295 small proteins (40-120 residues) from the PDB • Structure factor data also available • Resolution of 2.2 Å or better • Single molecule in the asymmetric unit • Mixture of all-α, all-β and mixed α-β secondary structure • 1000 decoys generated for each case using Rosetta • Information from any homologues was excluded from the fragment generation step

  16. Assessing Solutions • Initially we used Reforigin to compare solutions with the deposited structures • More stringent method: attempt to rebuild the structures • SHELXE: partial CC of >25% & average fragment length of 10 or more • Further confirmation provided through building with ARP/wARP and Buccaneer.

  17. Using these guidelines, 126 successes out of 295 (~43%) were achieved • These are solutions that could be successfully traced in SHELXE • Other well positioned solutions existed but could not be traced. These may be possible to solve through manual model building

  18. Results based on secondary structure type Overall success rate: all-α = 80%; all-β = 2%; mixed α-β = 37%

  19. Variance and Truncation • Variability between decoys in each cluster corresponds to their deviation from the deposited native structure • 2P5K example: C-terminal region predicted as least reliably modelled portion by Theseus alignment variance score

  20. Search model ensemble size/truncation

  21. Running Times • Average times for complete run (decoy generation, preparation, MR and chain tracing) was 2 CPU days • A parallelised version of the code making use of Sun Grid Engine for batch farming of model generation and molecular replacement significantly speeds up the process. Results can be achieved in less than 1 hour

  22. Exploiting distant homologues a. Clustered decoy models, b. Truncated ensemble, c. Positioned MR solution, d. Shelxe c-alpha trace, e. Completed structure

  23. Remodelling related NMR structures or distant homologues • Can provide AMPLE with a template for the target which could be a related NMR structure or a distant homologue • AMPLE will use Rosetta to “re-model” this template to something that should in theory be closer to the target

  24. Transmembrane Proteins • Experimentally very difficult to work with/crystallise • Represent ~30% of all proteins • Make up < 3% of structures in the Protein Data Bank • Presence in the membrane constrains their shape, so they can be easier to model • MR with abinitiotransmembrane models hasn't been tried yet extra cellular (aqueous) transmembrane region (hydrophobic) intra cellular (aqueous) • Image: http://en.wikiversity.org/wiki/File:Cytochrome_C_Oxidase_1OCC_in_Membrane_2.png

  25. Selected 18 transmembrane proteins: • 23 – 249 residues • 1.45 – 2.5A resolution • 7 clear successes • 5 possible successes • 223 residue structure (3GD8) could be largest ever solved with ab initio modelling.

  26. Selected 18 transmembrane proteins: • 23 – 249 residues • 1.45 – 2.5A resolution • 7 clear successes • 5 possible successes • 223 residue structure (3GD8) could be largest ever solved with ab initio modelling.

  27. Coiled-coil targets • Difficult to solve in MR even with good homologues • α-helical nature makes them suitable targets for AMPLE • Initial testing has been very promising with 80% success rate • Some novel structures have also been solved

  28. AMPLE Availability • Beta version available as part of CCP4 6.3.0. • Improved and more robust version to be released as part of CCP4 6.4.0. • Requires installation of several non-ccp4 packages: • Rosetta, SHELXE, Theseus, SPICKER, Maxcluster • Future versions will have a reduced number of dependencies

  29. Documentation available from http://ccp4wiki.org

  30. Summary • AMPLE is a pipeline designed to prepare cheaply obtained decoy models from ab initio modelling for use as search models in molecular replacement • Results show that the method works well for smaller proteins particularly those containing α-helical secondary structure • Tests were limited to structures of 120 residues in length but has worked for cases up to 250 residues • New avenues – NMR, Homologue remodelling • Several real successes • Currently available as a beta-version in CCP4 6.3.0

  31. Acknowledgements • Jaclyn Bibby, Daniel Rigden, Jens Thomas, University of Liverpool • Olga Mayans, University of Liverpool • Martyn Winn, Daresbury Laboratory • Andrea Thorn, Tim Gruene & George Sheldrick (SHELX) • Developers of Rosetta and Quark • Refmac: Garib Mushudov, LMB-MRC Cambridge • Molrep: Alexei Vagin & Andrey Lebedev • Phaser: Randy Read, Airlie McCoy & Gabor Bunkozci • Thanks to authors of all underlying programs • Funding: • BBSRC • Support from CCP4 & the Research Complex at Harwell Poster: MS04-12 (Rootes Building)

More Related